Angelova PR, Abramov AY (2018) Role of mitochondrial ROS in the brain: from physiology to neurodegeneration. FEBS LETT 592(5):692–702
Article CAS PubMed Google Scholar
Bao J, Liu W, Zhou HY, Gui YR, Yang YH, Wu MJ, Xiao YF, Shang JT, Long GF, Shu XJ (2020) Epigallocatechin-3-gallate alleviates cognitive deficits in APP/PS1 mice. CURR MED SCI 40(1):18–27
Article CAS PubMed Google Scholar
Billingham LK, Stoolman JS, Vasan K, Rodriguez AE, Poor TA, Szibor M, Jacobs HT, Reczek CR, Rashidi A, Zhang P, Miska J, Chandel NS (2022) Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation. NAT IMMUNOL 23(5):692–704
Article CAS PubMed PubMed Central Google Scholar
Chen J, Sun J, Hu Y, Wan X, Wang Y, Gao M, Liang J, Liu T, Sun X (2021) MicroRNA-191-5p ameliorates amyloid-β (1–40) -mediated retinal pigment epithelium cell injury by suppressing the NLRP3 inflammasome pathway. FASEB J 35(4):e21184
Article CAS PubMed Google Scholar
Dominic A, Le NT, Takahashi M (2022) Loop between NLRP3 inflammasome and reactive oxygen species. ANTIOXID REDOX SIGN 36(10–12):784–796
Du J, Wang Y, Tu Y, Guo Y, Sun X, Xu X, Liu X, Wang L, Qin X, Zhu M, Song E (2020) A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Müller cells. EXP EYE RES 196:108065
Article CAS PubMed Google Scholar
Edwards FA (2019) A unifying hypothesis for Alzheimer’s Disease: from plaques to Neurodegeneration. TRENDS NEUROSCI 42(5):310–322
Article CAS PubMed Google Scholar
Fujimura K, Karasawa T, Komada T, Yamada N, Mizushina Y, Baatarjav C, Matsumura T, Otsu K, Takeda N, Mizukami H, Kario K, Takahashi M (2023) NLRP3 inflammasome-driven IL-1β and IL-18 contribute to lipopolysaccharide-induced septic cardiomyopathy. J MOL CELL CARDIOL 180:58–68
Article CAS PubMed Google Scholar
Huang Y, Xu W, Zhou R (2021) NLRP3 inflammasome activation and cell death. CELL MOL IMMUNOL 18(9):2114–2127
Article CAS PubMed PubMed Central Google Scholar
Jian M, Kwan JS, Bunting M, Ng RC, Chan KH (2019) Adiponectin suppresses amyloid-β oligomer (AβO)-induced inflammatory response of microglia via AdipoR1-AMPK-NF-κB signaling pathway. J NEUROINFLAMM 16(1):110
Kochman J, Jakubczyk K, Antoniewicz J, Mruk H, Janda K (2020) Health benefits and Chemical composition of Matcha Green Tea: a review. Molecules 26(1):85
Article PubMed PubMed Central Google Scholar
Lee YJ, Choi DY, Yun YP, Han SB, Oh KW, Hong JT (2013) Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties. J NUTR BIOCHEM 24(1):298–310
Article CAS PubMed Google Scholar
Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? NAT REV NEUROL 17(3):157–172
Li L, Ismael S, Nasoohi S, Sakata K, Liao FF, McDonald MP, Ishrat T (2019) Thioredoxin-interacting protein (TXNIP) Associated NLRP3 Inflammasome activation in human Alzheimer’s Disease Brain. J ALZHEIMERS DIS 68(1):255–265
Article CAS PubMed PubMed Central Google Scholar
Long Y, Liu X, Tan XZ, Jiang CX, Chen SW, Liang GN, He XM, Wu J, Chen T, Xu Y (2020) ROS-induced NLRP3 inflammasome priming and activation mediate PCB 118- induced pyroptosis in endothelial cells. ECOTOX ENVIRON SAFE 189:109937
Luo T, Zhou X, Qin M, Lin Y, Lin J, Chen G, Liu A, Ouyang D, Chen D, Pan H (2022) Corilagin Restrains NLRP3 Inflammasome Activation and Pyroptosis through the ROS/TXNIP/NLRP3 Pathway to Prevent Inflammation. OXID MED CELL LONGEV. 2022: 1652244
Mohamed IN, Li L, Ismael S, Ishrat T, El-Remessy AB (2021) Thioredoxin interacting protein, a key molecular switch between oxidative stress and sterile inflammation in cellular response. WORLD J DIABETES 12(12):1979–1999
Article PubMed PubMed Central Google Scholar
Shimodaira T, Matsuda K, Uchibori T, Sugano M, Uehara T, Honda T (2018) Upregulation of osteopontin expression via the interaction of macrophages and fibroblasts under IL-1b stimulation. Cytokine 110:63–69
Article CAS PubMed Google Scholar
Takahashi M (2022) NLRP3 inflammasome as a key driver of vascular disease. CARDIOVASC RES 118(2):372–385
Article CAS PubMed Google Scholar
Valverde-Salazar V, Ruiz-Gabarre D, García-Escudero V (2023) Alzheimer’s Disease and Green Tea: Epigallocatechin-3-Gallate as a modulator of inflammation and oxidative stress. ANTIOXIDANTS-BASEL 12(7):1460
Article CAS PubMed PubMed Central Google Scholar
Zhang Q, Wu Y, Guan Y, Ling F, Li Y, Niu Y (2019) Epigallocatechin gallate prevents senescence by alleviating oxidative stress and inflammation in WI-38 human embryonic fibroblasts. RSC ADV 9(46):26787–26798
Article CAS PubMed PubMed Central Google Scholar
Zhang Y, Dong Z, Song W (2020a) NLRP3 inflammasome as a novel therapeutic target for Alzheimer’s disease. SIGNAL TRANSDUCT TAR 5(1):37
Zhang S, Zhu Q, Chen JY, OuYang D, Lu JH (2020b) The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer’s disease animal model: a systematic review. Phytomedicine 79:153316
Article CAS PubMed Google Scholar
Zhong X, Liu M, Yao W, Du K, He M, Jin X, Jiao L, Ma G, Wei B, Wei M (2019) Epigallocatechin-3-Gallate attenuates microglial inflammation and neurotoxicity by suppressing the activation of Canonical and Noncanonical Inflammasome via TLR4/NF-κB pathway. MOL NUTR FOOD RES 63(21):e1801230
留言 (0)